Cambridge, MA, United States of America

Ross A Fredenburg


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ross A. Fredenburg: Innovator in Neurodegenerative Disease Treatment

Introduction

Ross A. Fredenburg is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of neurodegenerative diseases. He holds a patent that focuses on innovative treatments for conditions such as Parkinson's Disease and other related disorders. His work is pivotal in advancing therapeutic options for patients suffering from these debilitating conditions.

Latest Patents

Fredenburg's most recent patent is titled "Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications." This patent introduces novel quinolinone farnesyl transferase inhibitors that are beneficial in treating or preventing synucleinopathies, including Parkinson's Disease, Diffuse Lewy Body Disease, and multiple system atrophy. Additionally, these compounds are useful in addressing disorders related to brain iron concentration and other neurodegenerative diseases. The treatment involves administering a therapeutically effective amount of the inventive farnesyl transferase inhibitor compound.

Career Highlights

Fredenburg is associated with Link Medicine Corporation, where he continues to develop innovative solutions for complex medical challenges. His work has garnered attention for its potential impact on treating not only neurodegenerative diseases but also proliferative diseases such as cancer, as well as neurological conditions like cognitive impairment, depression, and anxiety.

Collaborations

Fredenburg has collaborated with esteemed colleagues, including Peter T. Lansbury and Craig J. Justman, to further enhance the research and development of his innovative compounds. Their combined expertise contributes to the advancement of therapeutic strategies in the medical field.

Conclusion

Ross A. Fredenburg's contributions to the treatment of neurodegenerative diseases through his innovative patents highlight the importance of research and collaboration in the medical community. His work continues to pave the way for new therapeutic options that can significantly improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…